Man sees deadly brain tumour shrink by half thanks to new radioactive therapy
- A man has experienced a 50% reduction in his deadly brain tumour due to a new radioactive therapy, marking a significant development in treatment.
- Paul Read, a 62-year-old engineer, is the first patient in this trial, witnessing a remarkable tumour size decrease in just weeks.
- The trial aims to find effective treatments for aggressive tumours, as survival chances were initially under a year.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left2Leaning Right4Center2Last UpdatedBias Distribution50% Right
Bias Distribution
- 50% of the sources lean Right
50% Right
L 25%
C 25%
R 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage